A detailed history of Pro Share Advisors LLC transactions in Astrazeneca PLC stock. As of the latest transaction made, Pro Share Advisors LLC holds 580,460 shares of AZN stock, worth $38 Million. This represents 0.11% of its overall portfolio holdings.

Number of Shares
580,460
Previous 529,578 9.61%
Holding current value
$38 Million
Previous $41.3 Million 9.51%
% of portfolio
0.11%
Previous 0.11%

Shares

16 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 13, 2024

BUY
$76.67 - $87.62 $3.9 Million - $4.46 Million
50,882 Added 9.61%
580,460 $45.2 Million
Q2 2024

Aug 13, 2024

SELL
$66.81 - $80.83 $5.29 Million - $6.4 Million
-79,195 Reduced 13.01%
529,578 $41.3 Million
Q1 2024

May 08, 2024

BUY
$61.03 - $69.57 $7.41 Million - $8.45 Million
121,428 Added 24.92%
608,773 $41.2 Million
Q4 2023

Feb 14, 2024

SELL
$61.89 - $69.28 $5.55 Million - $6.22 Million
-89,724 Reduced 15.55%
487,345 $32.8 Million
Q3 2023

Nov 13, 2023

BUY
$64.85 - $71.7 $5.11 Million - $5.65 Million
78,752 Added 15.8%
577,069 $39.1 Million
Q2 2023

Aug 10, 2023

SELL
$69.91 - $75.81 $3.19 Million - $3.46 Million
-45,681 Reduced 8.4%
498,317 $35.7 Million
Q1 2023

May 11, 2023

BUY
$63.15 - $71.6 $2.06 Million - $2.33 Million
32,550 Added 6.36%
543,998 $37.8 Million
Q4 2022

Feb 02, 2023

SELL
$54.21 - $70.44 $3.19 Million - $4.14 Million
-58,798 Reduced 10.31%
511,448 $34.7 Million
Q3 2022

Nov 04, 2022

SELL
$53.02 - $135.75 $5.05 Million - $12.9 Million
-95,159 Reduced 14.3%
570,246 $31.3 Million
Q2 2022

Aug 01, 2022

SELL
$59.26 - $71.14 $18.1 Million - $21.8 Million
-305,936 Reduced 31.5%
665,405 $44 Million
Q1 2022

May 10, 2022

BUY
$55.72 - $67.12 $49.4 Million - $59.5 Million
885,947 Added 1037.48%
971,341 $64.4 Million
Q4 2021

Feb 08, 2022

BUY
$54.02 - $63.83 $1.01 Million - $1.19 Million
18,672 Added 27.98%
85,394 $4.97 Million
Q3 2021

Nov 12, 2021

BUY
$55.56 - $60.79 $146,122 - $159,877
2,630 Added 4.1%
66,722 $4.01 Million
Q2 2021

Aug 13, 2021

BUY
$48.42 - $60.18 $24,355 - $30,270
503 Added 0.79%
64,092 $3.84 Million
Q1 2021

May 14, 2021

SELL
$47.16 - $54.44 $561,015 - $647,618
-11,896 Reduced 15.76%
63,589 $3.16 Million
Q4 2020

Feb 09, 2021

BUY
$48.52 - $58.02 $3.66 Million - $4.38 Million
75,485 New
75,485 $3.77 Million

Others Institutions Holding AZN

About ASTRAZENECA PLC


  • Ticker AZN
  • Exchange OTC
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 3,099,020,032
  • Market Cap $203B
  • Description
  • AstraZeneca PLC, a biopharmaceutical company, focuses on the discovery, development, manufacturing, and commercialization of prescription medicines. Its marketed products include Calquence, Enhertu, Faslodex, Imfinzi, Iressa, Koselugo, Lumoxiti, Lynparza, Orpathys, Tagrisso, and Zoladex for oncology; Brilinta/Brilique, Bydureon/Byetta, BCise, By...
More about AZN
Track This Portfolio

Track Pro Share Advisors LLC Portfolio

Follow Pro Share Advisors LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Pro Share Advisors LLC, based on Form 13F filings with the SEC.

News

Stay updated on Pro Share Advisors LLC with notifications on news.